The most promising procedure to restore fertility in male childhood cancer patients is spermatogonial stem cell transplantation (SSCT). Although the efficiency of SSCT has been proven in the mouse model, its safety needs to be investigated too before considering any implementation in the clinic. To examine the incidence of genetic abnormalities after SSCT, the karyotypes of donor-derived spermatozoa and offspring were analyzed.
Introduction
Sterility can occur as a major side effect of cancer treatment. In some patients, fertility will restore spontaneously. Yet, patients who have high-dose chemotherapy and/or total body irradiation are at risk for lifelong infertility. At present, there are no options to preserve fertility in prepubertal boys. Cryopreservation of spermatogonial stem cells prior to cancer treatment followed by autologous spermatogonial stem cell transplantation (SSCT) after their cure is an option that is currently under investigation by a few research groups (for reviews see Geens et al., 2008 and Wyns et al., 2010) . However, before accepting SSCT as a clinical strategy, all potential safety concerns need to be carefully evaluated. So far, only a few reports have addressed these safety issues, namely those related to transplanting cells other than SSC, i.e. malignant cells present in the testis (Jahnukainen et al., 2001; Fujita et al., 2005 Fujita et al., , 2006 Geens et al., 2007) , and those related to modifications in the germ line cells, e.g. changes in imprinting, or chromosomal abnormalities. Unfortunately, compared with the increasing body of evidence illustrating the effectiveness of SSCT in reproductive terms, only few studies have addressed the latter safety concerns. Karyotyping spermatozoa and offspring after SSCT
Because to date any further data are lacking, the aim of the present study was to further examine the possible occurrence of genetic alterations associated with SSCT in mice. We examined the karyotype of donor-derived spermatozoa and offspring using an array comparative genomic hybridization (aCGH) analysis, a technique developed to detect genomic copy number variations at a higher resolution level than G-banding of chromosomes and fluorescence in situ hybridization (Vermeesch et al., 2005) .
Materials and Methods
All experimental procedures were approved by the Animal Care and Use Committee at the Brussels Free University.
DNA from spermatozoa, liver and kidney was obtained from samples used in our previous study of DNA methylation (Goossens et al., 2003) . In case the DNA concentration was too low to perform aCGH (concentration has to be 7 ng/ml), genomic DNA was amplified using the REPLI-g w Mini Kit (150023; Qiagen). Genomic DNA (150 ng) was labeled with the BioPrime w labeling kit (45-0048; Invitrogen, Merelbeke, Belgium) according to the protocol for Agilent microarrays (http://www.chem.agilent.com/Library/usermanuels/ Public/G4410-90010_CGH_Protocol_v5.pdf). Random primers (2.5×, 20 ml) and NaCl (1 ml; S-5886; Sigma, Bornem, Belgium) were added to the genomic DNA. Nuclease-free water was added to obtain a volume of 44 ml. The samples were denatured at 1008C for 5 min and immediately cooled on ice water. To this reaction, 5 ml 10× dCTP mix, 1 ml exo-Klenow fragment and 0.7 ml Cy3-dCTP (PA53021; GE Healthcare, Diegem, Belgium) or Cy5-dCTP (PA55 021; GE Healthcare) was added. Because of the photosensitivity of the labels, further handling of the samples was performed in the dark. Samples were incubated for 16 h on 378C and put on ice water. The test sample and the reference sample (DNA from C57Bl/WBRej mice) were mixed and 10 ml 3 M NaAc (pH 5.2) (S-2889; Sigma) and 250 ml 100% ethanol were added to the mixture. Co-precipitation was allowed to take place for 30 min at 2808C. The precipitated DNA was centrifuged for 15 min at 14 000g at 48C. After removal of the supernatant, the sample was again centrifuged for 1 min at 18 700g. The pellet was air-dried before 42 ml TE buffer (12090-015; Invitrogen) was added. After incubation for 2-3 h at 428C, 5 ml Cot-1 DNA (18440-016; Invitrogen), 11 ml Agilent blocking agent and 55 ml 2× hybridization buffer was added (from the Agilent hybridization kit 5188-5220; Waldbronn, Germany). Denaturation was allowed to take place for 3 min at 958C and 30 min at 378C.
Arrays (design format 4x44k; design ID 024413; Agilent) were loaded with 100 ml sample and put in a hybridization oven at 658C for 24 h. Oligonucleotide-based arrays were used encompassing the whole genome with on average one probe every 60 kb. Arrays were disassembled and washed in buffer 1 (5188-5221; Agilent) for 5 min, washed in prewarmed buffer 2 (378C, 5188-5222; Agilent) for 1 min and put in acetonitrile (100-4; Sigma) for 1 min. Finally, arrays were moved to stabilization and drying buffer (5185-5979; Agilent) for 30 s.
Arrays were scanned at 550 nm (Cy3) and 650 nm (Cy5) using an Agilent MicroArrayScannerSystem. Image analysis was performed with Agilent feature extraction software 9.5.3.1. All further data analysis was done using Excel. For each probe, a ratio of Cy5 to Cy3 fluorescence intensity was calculated. Data normalization was achieved by dividing the fluorescence intensity ratio of each spot by the median of the ratios of the autosomes. From the normalized ratios, log2 values were calculated. Arrays were performed in duplicate: a regular (test sample compared with reference) and a reverse (reference compared with test sample) arrays. To combine both arrays, the log2 ratios were averaged and used to calculate cleanlog2 ratios and the standard deviation (SD). A deletion or amplification was identified when the SD of the intensity ratios was not higher than 0.20, when at least three subsequent cleanlog2 ratios fell outside the threshold level (4×SD) and when the deletion or amplification was detectable in both the regular and the reverse arrays (ShawSmith et al., 2004; van den Ijssel et al., 2005) .
Results
Six aCGH analyses were performed on spermatozoa obtained from six transplanted animals. Apart from two genetic gains in spermatozoa from one transplanted mouse, chromosome number changes and small genetic deviations could not be detected (Table I, Fig. 1top ). Because three samples had DNA concentrations which were too low, whole-genome amplification was performed prior to aCGH analysis. However, the results obtained after whole-genome amplification were unsatisfying as the SD of the intensity ratios in these arrays were higher than 0.20. This means that the variation of the ratios was too high to make any valid conclusions, and therefore, these results were excluded for further analysis (Fig. 1bottom) .
In order to check the impact of SSCT on the genetic content of the germ cells in these transplanted animals, the karyotypes of their offspring were evaluated. Males that had been transplanted with C57Bl × WBRej F1 donor cells were mated with C57Bl females to generate first-and second-generation offspring. aCGH was performed on DNA from the liver, kidney and spermatozoa. An overview of the results can be found in Table I . All karyotypes analyzed showed normal chromosome numbers. However, chromosome 1, 3, 4, 7, 12, 14 and 17 were frequently subjected to deletions or amplifications (Fig. 2a) . Probes for which the intensity ratios of independent experiments repeatedly fall outside the cut-off level can be identified as polymorphisms (Vermeesch et al., 2005) . An aCGH analysis with DNA from a C57Bl mother hybridized against DNA from a C57Bl/ WBRej male showed that every gain or loss found in the offspring was also detected in the mother, confirming that these genetic abnormalities were indeed polymorphisms (Fig. 2b) .
Discussion
Before SSCT can be implemented in a clinical setting, the safety of this technique must be established. At present, no efficient solution is available for potential contamination of testicular cell suspensions by malignant cells which represents a direct safety issue. Although the use of magnetic-activated cell sorting (MACS) looked very promising in one report (Fujita et al., 2005) , we found MACS and FACS to be insufficient for completely depleting testicular suspensions of malignant cells (Geens et al., 2007) . However, apart from malignant contamination, the genetic integrity of the germ cell line obtained after SSCT has remained to be confirmed. Unfortunately, hardly any research has been done in this field. We reported earlier in a mouse model that SSCT was not associated with modifications in the methylation pattern of two imprinted genes (Igf2, Peg1) and one non-imprinted gene (a-Actin). The aim of the present study was to evaluate whether natural reproduction after SSCT causes an increase in chromosomal alterations in the offspring. Our data showed the absence of chromosome copy number changes as well as the nonappearance of smaller genetic deviations such as deletions and amplifications in spermatozoa and offspring produced after SSCT.
However, a total absence of irregularities could not be proven because when analyzing a pool of millions of spermatozoa, as the presence of an abnormal karyotype in only a small percentage of the spermatozoa remains undetectable. Arrays on single spermatozoa would be preferential, but very difficult to establish. Obtaining a low SD of the intensity ratios would be a technical challenge when performing aCGH on single spermatozoa, because then whole-genome amplification is required prior to aCGH. In the present study, whole-genome amplification had a negative influence on the SD. All arrays carried out following whole-genome amplification presented an SD higher than 0.30 and therefore had to be excluded from our study.
Because of the difficulties inherent to the analysis of spermatozoa, we opted to evaluate the offspring as well. Apart from polymorphisms between strains, we could not detect any changes in chromosome number, nor deletions or amplifications. The risk that SSCT may introduce genetic abnormalities in the offspring is not supported by the findings in this study. Yet, the resolution of the arrays used was 60 kb. Although using arrays with a high resolution will definitely decrease the probability of missing mutations, they may also increase the number of false-positive genetic alterations (polymorphisms).
Although we considered the arrays to be adequate enough for studying gross genomic alterations after SSCT, molecular karyotyping still has its limitations. It fails to identify structural chromosome aberrations such as balanced reciprocal translocations or inversions, which by definition do not present genomic losses or gains. Also, ploidy variations may not be detected by aCGH, as the technique relies on normalization of intensity ratios. Although these anomalies can be detected by fluorescence in situ hybridization, this approach requires a priori knowledge of the chromosomal regions of interest and is thus not applicable for whole-genome screening.
A clinical study reported SSCT in cancer patients; however, no information is available on the fertility of these patients (Radford, 2003) . At present, more clinical programs are starting to cryopreserve testicular tissue from prepubertal boys before potentially sterilizing treatments. Soon, when they are cured, these boys will return to the clinic for autologous transplantation of their preserved spermatogonial stem cells and thus more research is needed to confirm the safety of SSCT. The findings of the present study are reassuring since no major genetic alterations could be detected after SSCT. Our results support further clinical development of this promising technique.
Authors' roles E.G.: conception and design, analysis and interpretation of data, writing the article and final approval of the version to be published. P.dV.: acquisition of data, revising the article and final approval of the version to be published. H.T.: conception and design, writing the article and final approval of the version to be published. aCGH on spermatozoa of transplanted mouse no. 2. No genomic gains or losses could be detected. The cluster (green box) corresponds to a 5-fold repetition of the same probe (top). When whole-genome amplification had to be performed because the DNA concentration was too low, the variation of the intensity ratios was too high to make valid conclusions (bottom). The pink bars represent the 4×SD threshold level.
Figure 2 aCGH on offspring after SSCT.
A detailed graph of the karyotype of first-generation offspring no. 7 showing the cleanlog2 ratios for each chromosome separately. Every genomic gain or loss found in the offspring (a) could also be identified in the mother (b), implicating that these genetic abnormalities were in fact polymorphisms. The cluster (red boxes) on chromosome 17 corresponds to a 5-fold repetition of the same probe. The pink bars represent the 4×SD threshold level. Karyotyping spermatozoa and offspring after SSCT
